Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
22 hedge funds and large institutions have $5.64M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 9 closing their positions.
27% less funds holding
Funds holding: 30 → 22 (-8)
39% less capital invested
Capital invested by funds: $9.25M → $5.64M (-$3.61M)
80% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 10
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
+$333K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.68K |
| 3 |
Morgan Stanley
New York
|
+$1.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$479K |
| 2 |
SCM
Sio Capital Management
New York
|
-$305K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$272K |
| 4 |
VF
Virtu Financial
New York
|
-$146K |
| 5 |
CC
Clearline Capital
New York
|
-$90K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| – | -$15K | -39 | Closed |
|
27
Dimensional Fund Advisors
Austin,
Texas
| – | -$14K | -36 | Closed |
|
28
Simplex Trading
Chicago,
Illinois
| – | -$3.35K | -10 | -77% |
|
FRTX Hedge Fund Activity: Q2 2019 in Review
22 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2019, worth a combined $5.64M — down 39% from $9.25M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of FRTX and 1 opened new positions — a net loss of 8 holders — while 10 trimmed existing stakes and 2 added.
The largest buyer was Fosun International, opening a new position worth an estimated $333K. The largest seller was BVF Inc, cutting an estimated $479K.
- 22 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2019, down from 30 in Q1 2019.
- Funds reported $5.64M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2019, down 39% quarter-over-quarter.
- 1 fund opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2019 and 9 closed out, a net change of -8 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2019 was Fosun International, an estimated $333K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2019 was BVF Inc, an estimated $479K sold.
Based on aggregated 13F filings for Q2 2019.